Eli Lilly (LLY)
(Delayed Data from NYSE)
$783.18 USD
+13.18 (1.71%)
Updated May 20, 2024 04:00 PM ET
After-Market: $783.16 -0.02 (0.00%) 6:12 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
Eli Lilly and Company [LLY]
Reports for Purchase
Showing records 161 - 180 ( 428 total )
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Biotechnology: Neurology Prescription Sales Tracker -- Week Ending 6/5/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L